BioSpace News Archive

Drug Development

Progenity Provides Results from Key Study for Its Targeted Therapeutics Program

Progenity , Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced results from a further study for the company’s Targeted Therapeutics program. The study evaluated delivery of Progenity’s PGN-001 (adalimumab) drug substance directly to the colon in a preclinical model of colitis.

May 26, 2021
·
7 min read
High Content Screening Market | Expansive Coverage Report on the Latest Technological Developments in the Market

High-content screening technologies have the ability of simultaneously studying multiple parameters in complex biological systems, a factor that is also one of the key factors driving the global market for high-content screening.

May 26, 2021
·
5 min read
High Throughput Process Development Market | Current Insight with Future Aspect Analysis Report to 2025

The global market for high throughput process development is expected to grow alongside the biopharmaceutical industry.

May 26, 2021
·
5 min read
Pharm Country

New Study Confirms That Novel Liquid Levothyroxine Solution Can be Administered as Early as 15 Minutes Before Breakfast

A new study demonstrates the ability of a novel liquid formulation of levothyroxine, TirosintSol® developed and commercialized in the United States by IBSA Pharma Inc., to be administered as early as 15 minutes before breakfast without interfering with absorption and systemic availability

May 26, 2021
·
7 min read
Cell MedX Corp. Converts Debt to Shares, Closes Non-Brokered Private Placement Financing, and Engages Investor Relations Consultants

Concurrently with conversion of debt, the Company closed a non-brokered private placement financing at a price of $0.20 per Share, by issuing 200,000 Shares for total gross proceeds of $40,000.

May 26, 2021
·
4 min read
Business

University of California, San Francisco joins forces with Philips to enhance the digital patient experience with Philips HealthSuite

Collaboration takes a Silicon Valley approach to the Quadruple Aim, setting new standard for modern healthcare with end-to-end cloud-based interoperability and innovative AI

May 26, 2021
·
5 min read
BioCapital

Inteleos Announces MedGlobal and Global Ultrasound Institute as MissionPOCUS Selection for 2021

The Point-of-Care Ultrasound Certification Academy under Inteleos announced a pilot project with MedGlobal and the Global Ultrasound Institute as the selection of their MissionPOCUS™ project for 2021.

May 26, 2021
·
2 min read
Business

Anivive Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Newest Lymphoma Treatment for Dogs

Strategic collaboration ensures veterinarians have rapid, easy access to LAVERDIA™-CA1 (verdinexor), the first oral tablet conditionally approved by the U.S. Food and Drug Administration (FDA) to treat lymphoma in dogs

May 26, 2021
·
3 min read
Business

Foundation for Sarcoidosis Research Welcomes Three New Members to its Board of Directors

The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, is pleased to announce the appointment of three new members to its Board of Directors.

May 26, 2021
·
3 min read
Policy

Government of Canada Announces Funding for COVID-19 Safe Voluntary Isolation Sites in Nova Scotia

The Government of Canada is working with all partners to protect the health and safety of Canadians and to reduce the spread of COVID-19 and the variants of concern in Canada.

May 26, 2021
·
3 min read